Fibrinogen Concentrate for the Treatment of Thrombolysis-Associated Hemorrhage in Adult Ischemic Stroke Patients

In patients with ischemic stroke who receive systemic recombinant tissue plasminogen activator (rt-PA), the risk of secondary hemorrhage is 1-7%. Fibrinogen supplementation with cryoprecipitate is recommended in patients with rt-PA-associated symptomatic hemorrhage. We examined whether fibrinogen co...

Descripción completa

Detalles Bibliográficos
Autores principales: Barra, Megan E., Feske, Steven K., Sylvester, Katelyn W., Ong, Charlene, Culbreth, Sarah E., Krause, Patricia, Henderson, Galen V., Rybak, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Therapeutic Approaches for the Treatment of Cerebral-Neurovascular Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502993/
https://www.ncbi.nlm.nih.gov/pubmed/32946279
http://dx.doi.org/10.1177/1076029620951867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502993/
https://www.ncbi.nlm.nih.gov/pubmed/32946279
http://dx.doi.org/10.1177/1076029620951867

Ejemplares similares